Thomas George Evans - 03 Jan 2023 Form 4 Insider Report for Vaccitech plc (BRNS)

Role
Fmr Chief Scientific Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
29 Mar 2023, 16:43:22 UTC
Previous filing
11 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 03 Jan 2023 Ordinary Shares 125,000 $2.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Thomas George Evans is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.